+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Management of tics and Tourette's disorder: an update



Management of tics and Tourette's disorder: an update



Expert Opinion on PharmacoTherapy 11(11): 1813-1822



Tic disorders are fairly prevalent neuropsychiatric disorders. While a proportion of children may not present to the clinician's office for management of tic disorders, another proportion may present with severe symptoms that impair social and occupational functioning. A combination of psychosocial interventions and pharmacological approaches are required in these cases. While alpha-2 agonists and dopamine antagonists constitute the mainstay of pharmacological agents for tic disorders, advances in neurobiology and psychopharmacology have discovered newer avenues for treatment of tic disorders. Apart from reviewing evidence based literature and recent updates on alpha-2 agonists and dopamine antagonists in treating tic disorders, the review also includes novel treatment approaches such as glutamate modulators, nicotinic agents, antiandrogens and botulinum injection. In addition, a brief overview of electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS) and habit reversal training is also provided. A clear and concise review of the therapeutic options and advances in management of tic disorders. In addition to psychosocial interventions, alpha-2 agonists and dopamine antagonists constitute the mainstay of treatment approaches for treating tic disorders. Additional treatment options such as ropinirole, pramipexole and tetrabenazine may be useful if patients do not respond to the primary agents. Severe intractable cases might need a referral to specialist centers to consider the possibility of using ECT, TMS or DBS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054247655

Download citation: RISBibTeXText

PMID: 20459362

DOI: 10.1517/14656566.2010.486402


Related references

Complex tics and complex management in a case of severe Tourette's disorder (TD) in an adolescent. Journal of Child and Adolescent Psychopharmacology 19(4): 469-474, 2009

Tics and Tourette's: update on pathophysiology and tic control. Current Opinion in Neurology 29(4): 513-518, 2016

An overview of the treatment of Tourette's disorder and tics. Journal of Child and Adolescent Psychopharmacology 20(4): 249-262, 2010

Psychogenic movement disorder (pseudo-tics) in a patient with Tourette's syndrome. Journal of Neuropsychiatry and Clinical Neurosciences 4(3): 347-348, 1992

Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. American Journal of Psychiatry 149(9): 1244-1251, 1992

Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder. Journal of Psychiatric Research 40(6): 487-493, 2006

The effects of sympathomimetic and antihistaminic agents on chronic motor tics and Tourette's disorder. New England Journal of Medicine 315(19): 1228-1229, 1986

Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 32(1): 211-214, 1993

Tics of Tourette: important points in management. Journal of Developmental and Behavioral Pediatrics 2(4): 166-167, 1981

Therapeutic management of tics in Tourette's syndrome. Revue Neurologique 163(3): 375-386, 2007

Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options. World Journal of Clinical Pediatrics 5(1): 128-135, 2016

The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder. Journal of Child and Adolescent Psychopharmacology 26(5): 442-448, 2016

Anti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approaches. Journal of Pharmaceutical Analysis 8(2): 109-118, 2018

Tourette's syndrome, chronic tics, and comorbid attention deficit/hyperactivity disorder in elementary students. Archives of Iranian Medicine 15(2): 76-78, 2012